Endoscopic intervention is considered to be the primary treatment for biliary stricture after adult living donor liver transplantation (LDLT) with duct-to-duct biliary reconstruction. The aim of this study was to investigate the risk factors of biliary stricture and the clinical outcomes and predict
Bile duct anastomotic stricture after adult-to-adult right lobe living donor liver transplantation
β Scribed by Kenneth Siu Ho Chok; See Ching Chan; Tan To Cheung; William Wei Sharr; Albert Chi Yan Chan; Chung Mau Lo; Sheung Tat Fan
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 131 KB
- Volume
- 17
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.22188
No coin nor oath required. For personal study only.
β¦ Synopsis
Duct-to-duct anastomosis (DDA) and hepaticojejunostomy (HJ) are options for biliary reconstruction in patients undergoing adult-to-adult right lobe living donor liver transplantation (ARLDLT), after which biliary anastomotic stricture (BAS) is common as a complication. The risk factors for BAS are not clearly defined. We aimed to determine the rate of post-ARLDLT BAS in our center and its associated factors. In 265 ARLDLT recipients, 55 (20.8%) developed postoperative BAS. The diagnosis was based on clinical, biochemical, histological, and radiological results. The BAS rates were 21.4% (43/201) for recipients undergoing DDA during transplantation, 18.9% (10/53) for recipients undergoing HJ, and 18.2% (2/11) for recipients undergoing both procedures. BAS and non-BAS patients had comparable demographics. The number of graft bile duct openings (P ΒΌ 0.516) and the size of the graft's smallest bile duct (5 versus 5 mm, P ΒΌ 0.4) were not significantly different between BAS and non-BAS patients. Univariate analysis showed that the factors associated with postoperative BAS were the recipient warm ischemia time (55 versus 51 minutes, P ΒΌ 0.026), graft cold ischemia time (120 versus 108 minutes, P ΒΌ 0.046), stent use (21.8% versus 7.1%, P ΒΌ 0.001), postoperative acute cellular rejection (29.1% versus 11.0%, P ΒΌ 0.001), and University of Wisconsin solution use (21.8% versus 7.1%, P ΒΌ 0.001). Multivariate analysis showed that the cold ischemia time (odds ratio ΒΌ 1.012, 95% confidence interval ΒΌ 1.002-1.023, P ΒΌ 0.014) and acute rejection (odds ratio ΒΌ 3.180, 95% confidence interval ΒΌ 1.606-6.853, P ΒΌ 0.002) were significant factors. The graft survival rates of BAS and non-BAS patients were comparable. One patient required retransplantation for secondary biliary cirrhosis. In conclusion, BAS remains common after ARLDLT regardless of DDA or HJ. The graft cold ischemia time and postoperative acute cellular rejection are significantly associated with postoperative BAS.
π SIMILAR VOLUMES
Donor right hepatectomy for adult-to-adult live donor liver transplantation (ALDLT) is a major surgical operation for the benefit of the recipient. Justification of procedure mandates knowledge of the possible physical and psychological negative effects on the donor. We prospectively and longitudina
In a consecutive series of 60 right lobe adult-to-adult live donor liver transplantations (ALDLTs), safety and efficacy of the University of Wisconsin (UW) and histidine-tryptophan-ketoglutarate (HTK) solution were evaluated. The first 30 liver grafts were perfused with UW solution and the subsequen
There is no accurate method to determine the functional significance of bile duct strictures after liver transplantation, and although biliary reconstructive surgery (Rouxen-Y hepaticojejunostomy, HJ) is the second-line treatment in patients with persistent allograft dysfunction following failed end
The problem of graft size is one of the critical factors limiting the expansion of adult-to-adult living donor liver transplantation (LDLT). We compared the outcome of LDLT recipients who received grafts with a graft-to-recipient weight ratio (GRWR) < 0.8% or a GRWR 0.8%, and we analyzed the risk fa
Adult-to-adult living donor liver transplantation is an accepted treatment option for patients with end-stage liver disease. It is generally acknowledged that a graft weight to recipient body weight ratio > 0.8 is required in order to prevent the development of small-for-size syndrome. Size mismatch